WO2019004792A3 - 인간 유래 심장 줄기세포 미세구의 제조 방법 및 용도 - Google Patents
인간 유래 심장 줄기세포 미세구의 제조 방법 및 용도 Download PDFInfo
- Publication number
- WO2019004792A3 WO2019004792A3 PCT/KR2018/007433 KR2018007433W WO2019004792A3 WO 2019004792 A3 WO2019004792 A3 WO 2019004792A3 KR 2018007433 W KR2018007433 W KR 2018007433W WO 2019004792 A3 WO2019004792 A3 WO 2019004792A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- cardiac stem
- human
- preparation
- microspheroid
- stem cell
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0662—Stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/34—Muscles; Smooth muscle cells; Heart; Cardiac stem cells; Myoblasts; Myocytes; Cardiomyocytes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/0068—General culture methods using substrates
- C12N5/0075—General culture methods using substrates using microcarriers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0657—Cardiomyocytes; Heart cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/38—Vitamins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/12—Hepatocyte growth factor [HGF]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/165—Vascular endothelial growth factor [VEGF]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/40—Regulators of development
- C12N2501/415—Wnt; Frizzeled
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/70—Enzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/998—Proteins not provided for elsewhere
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2513/00—3D culture
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Cell Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Developmental Biology & Embryology (AREA)
- Cardiology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Rheumatology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Vascular Medicine (AREA)
- Virology (AREA)
- Dermatology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
본 발명은 인간 유래 심장 줄기세포를 이용한 미세구의 제조 방법 및 이의 심근 재생 효과를 이용한 허혈성 심장질환 치료 용도에 관한 것이다. 본 발명에서 제공하는 심장 줄기세포를 이용한 미세구는 기존의 심장 줄기세포와 비교하여 우수한 심근분화능과 재생 치료능을 가져 심근경색과 같은 허혈성 심장질환의 치료 용도로 사용할 수 있을 것이다.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US16/627,258 US11692171B2 (en) | 2017-06-30 | 2018-06-29 | Preparation method of human-derived cardiac stem cell spheroid and use thereof |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020170083057A KR102182513B1 (ko) | 2017-06-30 | 2017-06-30 | 인간 유래 심장 줄기세포 미세구의 제조 방법 및 용도 |
KR10-2017-0083057 | 2017-06-30 |
Publications (3)
Publication Number | Publication Date |
---|---|
WO2019004792A2 WO2019004792A2 (ko) | 2019-01-03 |
WO2019004792A3 true WO2019004792A3 (ko) | 2019-04-11 |
WO2019004792A9 WO2019004792A9 (ko) | 2019-05-31 |
Family
ID=64742499
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/KR2018/007433 WO2019004792A2 (ko) | 2017-06-30 | 2018-06-29 | 인간 유래 심장 줄기세포 미세구의 제조 방법 및 용도 |
Country Status (3)
Country | Link |
---|---|
US (1) | US11692171B2 (ko) |
KR (1) | KR102182513B1 (ko) |
WO (1) | WO2019004792A2 (ko) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP4101440A4 (en) * | 2020-02-04 | 2024-02-21 | Hierabio Inc. | COMPOSITION FOR INTRAPERICARDIAL INJECTION WITH STEM CELLS AND USE THEREOF |
KR102367101B1 (ko) | 2020-03-09 | 2022-02-23 | 부산대학교 산학협력단 | 심장 보호 효과를 갖는 신규 화합물 및 이를 이용한 줄기세포 배양용 배지조성물 |
EP4349964A1 (en) * | 2021-05-31 | 2024-04-10 | Seoul National University Hospital | Preparation and standardization of cell spheroids for promoting tissue regeneration |
KR102455288B1 (ko) | 2021-12-03 | 2022-10-17 | 중앙대학교 산학협력단 | 신경구로부터의 생식선 줄기세포로의 전환방법 및 이의 용도 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20080267921A1 (en) * | 2004-11-08 | 2008-10-30 | Johns Hopkins University | Cardiac Stem Cells |
JP2012523238A (ja) * | 2009-04-09 | 2012-10-04 | ジ・アリゾナ・ボード・オブ・リージェンツ・オン・ビハーフ・オブ・ザ・ユニバーシティ・オブ・アリゾナ | 三次元繊維芽細胞構築物の細胞播種および共培養 |
WO2014141220A1 (en) * | 2013-03-15 | 2014-09-18 | Coretherapix Slu | Adult cardiac stem cell population |
CN104922155A (zh) * | 2014-03-18 | 2015-09-23 | 中山大学孙逸仙纪念医院 | 治疗心脏疾病的细胞输送方法 |
US20160244723A1 (en) * | 2003-07-31 | 2016-08-25 | Universita Degli Studi Di Roma "La Sapienza" | Cardiac stem cells and uses of same in cardiac repair |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101389850B1 (ko) | 2012-05-04 | 2014-04-29 | 이화여자대학교 산학협력단 | 심장전구세포의 배양방법 및 그 용도 |
-
2017
- 2017-06-30 KR KR1020170083057A patent/KR102182513B1/ko active IP Right Grant
-
2018
- 2018-06-29 WO PCT/KR2018/007433 patent/WO2019004792A2/ko active Application Filing
- 2018-06-29 US US16/627,258 patent/US11692171B2/en active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20160244723A1 (en) * | 2003-07-31 | 2016-08-25 | Universita Degli Studi Di Roma "La Sapienza" | Cardiac stem cells and uses of same in cardiac repair |
US20080267921A1 (en) * | 2004-11-08 | 2008-10-30 | Johns Hopkins University | Cardiac Stem Cells |
JP2012523238A (ja) * | 2009-04-09 | 2012-10-04 | ジ・アリゾナ・ボード・オブ・リージェンツ・オン・ビハーフ・オブ・ザ・ユニバーシティ・オブ・アリゾナ | 三次元繊維芽細胞構築物の細胞播種および共培養 |
WO2014141220A1 (en) * | 2013-03-15 | 2014-09-18 | Coretherapix Slu | Adult cardiac stem cell population |
CN104922155A (zh) * | 2014-03-18 | 2015-09-23 | 中山大学孙逸仙纪念医院 | 治疗心脏疾病的细胞输送方法 |
Also Published As
Publication number | Publication date |
---|---|
KR102182513B1 (ko) | 2020-11-25 |
US20200131479A1 (en) | 2020-04-30 |
KR20190003871A (ko) | 2019-01-10 |
WO2019004792A9 (ko) | 2019-05-31 |
WO2019004792A2 (ko) | 2019-01-03 |
US11692171B2 (en) | 2023-07-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2019004792A3 (ko) | 인간 유래 심장 줄기세포 미세구의 제조 방법 및 용도 | |
SA522432917B1 (ar) | ميوتينات إنترليوكين-21 وطرق العلاج | |
EP3736294A3 (en) | Cd73 blockade | |
MX2022014414A (es) | Compuestos de pirimidinodiona contra estados cardiacos. | |
WO2011057249A3 (en) | Treatment of heart disease | |
WO2011057251A3 (en) | Treatment of heart disease | |
AU2016255474A8 (en) | Application of PI4KIIIα protein and related membrane protein complex in treating Alzheimer's disease | |
WO2019118518A3 (en) | Inducible cell receptors for cell-based therapeutics | |
WO2010007031A3 (en) | Methods for improving cardiac differentiation of human embryonic stem cells | |
WO2016022536A3 (en) | Inhibitors of myh7b and uses thereof | |
WO2012135868A8 (en) | Compositions and methods for the treatment and prevention of cardiac ischemic injury | |
MX2022008273A (es) | Neurregulina para usarse en el tratamiento de lesion cardiaca. | |
MX2017005186A (es) | Celulas madre neurales estables que comprenden un polinucleótido exógeno que codifica un factor de crecimiento y métodos de uso de las mismas. | |
WO2012090194A3 (en) | Compositions and methods for treating a skin disorder | |
WO2016163799A3 (ko) | 2-메톡시-4-(3-(4-메톡시페닐)프로프-1-엔-1-일)페놀을 유효성분으로 하는 암의 치료용 약제학적 조성물 | |
WO2015074010A8 (en) | Compositions and methods for cardiac regeneration | |
WO2019027299A3 (ko) | 간세포성장인자를 발현하는 중간엽줄기세포를 유효성분으로 포함하는 혈관계 질환 예방 또는 치료용 약학 조성물 | |
WO2018158542A8 (fr) | Cellules souches mesenchymateuses issues de la gelée de wharton pour le traitement du sepsis | |
WO2020142740A8 (en) | Treatment of sjogren's disease with nuclease fusion proteins | |
CA2986376C (en) | Poxvirus-derived promoter, and vector comprising same | |
WO2016195247A3 (ko) | 전기·기계적 자극을 가하여 줄기세포를 심근세포로 분화시키는 방법 | |
WO2015143240A3 (en) | Compositions and methods comprising 2-(acylamino)imidazoles | |
WO2018085516A3 (en) | Non-mesenchymal human lung stem cells and methods of their use for treating respiratory diseases | |
WO2015112866A3 (en) | Compounds and methods for increasing hair growth | |
MX2020006856A (es) | Trombina secada por aspersion y metodos de uso y preparacion de trombina secada por aspersion. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 18823586 Country of ref document: EP Kind code of ref document: A2 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 18823586 Country of ref document: EP Kind code of ref document: A2 |